Epa modulates klk genes via mir-378: a potential therapy in prostate cancer

HIGHLIGHTS

  • who: Kai-Jie Yu et al. from the Department of Chemical Engineering and Biotechnology, Graduate Institute of Biochemical and Biomedical College of Medicine, Chang Gung University, Tao-Yuan, Taiwan have published the article: EPA Modulates KLK Genes via miR-378: A Potential Therapy in Prostate Cancer, in the Journal: Cancers 2022, 2813 of 28/04/2022
  • what: To eliminate background variation among the experiments, the PZ-HPV-7 cell line was used as a control group to normalize the two groups of cells treated with EPA medium and incubated with the control medium. The authors . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?